Dr. Grant Harrer
Claim this profileSletten Cancer Institute
Studies Ovarian Cancer
Studies Ovarian Tumors
1 reported clinical trial
4 drugs studied
Affiliated Hospitals
More about Grant Harrer
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Grant Harrer has experience with
- Mirvetuximab Soravtansine
- Paclitaxel
- Pegylated Liposomal Doxorubicin
- Topotecan
Breakdown of trials Grant Harrer has run
Ovarian Cancer
Ovarian Tumors
Fallopian Tube Cancer
Peritoneal Neoplasm
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Grant Harrer specialize in?
Grant Harrer focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved FRα positive patients, or patients who are undergoing treatment.
Is Grant Harrer currently recruiting for clinical trials?
No, Grant Harrer is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Grant Harrer has studied deeply?
Yes, Grant Harrer has studied treatments such as Mirvetuximab Soravtansine, Paclitaxel, Pegylated liposomal doxorubicin.
What is the best way to schedule an appointment with Grant Harrer?
Apply for one of the trials that Grant Harrer is conducting.
What is the office address of Grant Harrer?
The office of Grant Harrer is located at: Sletten Cancer Institute, Great Falls, Montana 59405 United States. This is the address for their practice at the Sletten Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.